GLP-1 Drugs: From Weight Loss to Alzheimer’s Care
GLP-1 Drugs Evolve from Obesity to Alzheimer’s: A Promising Therapeutic Approach Why in the News ? GLP-1-based drugs, initially developed for diabetes and later effective in obesity, are now being explored as a potential therapeutic intervention for Alzheimer’s disease and other neurodegenerative diseases. Research suggests GLP-1 may reduce brain inflammation and improve cognitive function, offering …
Read More
